ERBB2 and neoplasm: A multivariate model adjusted for pathologic tumor stage, histologic subtype, histologic grade, lymphatic invasion, and ER/HER2 status revealed that larger tumor size, lymphatic invasion, ER-/HER2-subtype, and HER2-positive subtype were factors associated with a higher odds ratio of performing ALND (Table 3).